Quality of Life on Trial

Λny tool that man develops has potential flaws, whether we choose to recognize them or not. The concept of evidence-based medicine (EBM), along with its established "gold standard," the N-ple blind randomized control trial (RCT), is no different. In clinical medicine, when we wish to ask a scientific question, such as the effectiveness of a medication or product, we conduct studies on a patient population. These studies are organized via a variety of different methods; the best regarded among them are what is called RCT. We call EBM the compilation and application of the information gathered from different studies, so as to obtain the best possible outcome for a patient population. Within the sphere of EBM, there are different classifications that are used to inform clinicians on how strongly regarded a concept may be (e.g., "aspirin should be used with anyone suspected of having a heart attack" is highly regarded). The classifications are often directly linked with the type of study or analysis; data resulting from RCTs are considered among the strongest form of EBM, second only to meta-analyses, which is the compilation of several RCTs.